| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.33B | 34.06B | 34.63B | 23.54B | 17.42B | 12.59B |
| Gross Profit | 9.76B | 8.41B | 6.46B | 6.87B | 6.14B | 3.86B |
| EBITDA | 2.25B | 2.85B | 456.30M | 1.88B | 1.27B | 363.20M |
| Net Income | 241.50M | 376.50M | 30.20M | 300.20M | 106.60M | -611.40M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 22.69B | 13.69B | 13.49B | 12.30B | 10.32B |
| Cash, Cash Equivalents and Short-Term Investments | 337.80M | 432.70M | 383.90M | 284.80M | 128.50M | 124.70M |
| Total Debt | 0.00 | 8.13B | 7.28B | 6.68B | 5.85B | 4.70B |
| Total Liabilities | -6.71B | 15.98B | 11.13B | 11.07B | 10.02B | 8.50B |
| Stockholders Equity | 6.71B | 6.71B | 2.56B | 2.42B | 2.28B | 1.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 637.00M | -171.00M | -206.80M | -1.06B | -346.80M |
| Operating Cash Flow | 0.00 | 2.48B | 1.20B | 876.40M | -56.50M | 459.10M |
| Investing Cash Flow | 0.00 | -1.53B | -1.57B | -1.06B | -1.24B | -799.70M |
| Financing Cash Flow | 0.00 | -1.02B | -553.60M | 351.20M | 1.34B | 210.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹5.13B | 33.54 | ― | 0.20% | 26.47% | -4.62% | |
69 Neutral | ₹17.95B | 18.69 | ― | 0.41% | 3.71% | -15.16% | |
63 Neutral | ₹9.91B | 19.50 | ― | 0.76% | 0.93% | 88.42% | |
62 Neutral | ₹2.59B | 14.34 | ― | ― | 13.93% | 0.25% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ₹23.32B | 83.07 | ― | 0.95% | 30.38% | -20.93% | |
51 Neutral | ₹3.96B | -6.94 | ― | ― | -9.04% | -10.81% |
Rane (Madras) Limited has announced a special window for the re-lodgement of transfer requests for physical shares, as per the SEBI Circular dated July 2, 2025. This move is part of the company’s compliance with SEBI regulations and aims to facilitate shareholders in managing their physical share transfers, reinforcing the company’s commitment to adhering to regulatory standards.